|
| |
BioEmail targeted email lists - Stem Cell Scientists email list
Stem Cell Scientists email list
This list enables you to promote your products and services to
academics, clinicians and commercial scientists involved in stem cell
research.
Current number on list : 6,931*
Regional Breakdown Percentage
-
USA 31.23%
-
Europe 26.65%
-
Rest of World 42.13%
Keywords:
• Tissue engineering
• Regenerative medicine
• Stem cell
• Cell therapy
• Cell transplantation
• Cellular therapy
Additional terms to consider to broaden list where appropriate:
• Neurodegenerative
• Altzhiemer’s
• Parkinson’s
• Development
• Gene Therapy (Cells as gene delivery vectors)
• Differentiation
• Toxicology (in vitro assays)
Top Countries
-
USA 31.2%
-
Japan 9.1%
-
Germany 6.6%
-
UK 5.4%
-
Italy 3.8%
-
France 3.2%
-
Canada 2.7%
-
Netherlands 2.2%
Sector Distribution
-
Academic (.ac., .edu etc.) 58.0%
-
Commercial (.com, .co.uk etc.) 4.0%
-
Government (.gov etc.) 0.9%
-
Other (Mainly country TLDs eg. .de, .jp
etc.) 37.1%
Example Job Titles:
• Senior scientist at XXX Therapeutics Inc.
• Head of the University Stem Cell Institute
• Post Doctoral Researcher
• Professor/Orthopaedic Surgery
• Professor of Anatomy and Co-Director of Department
Sample Grant Titles
xxx@path.uab.edu
Molecular Characterization of Neural Stem Cell Apoptosis
xxx@mri.jhu.edu
MR Tracking of Magnetically Labeled Stem Cells in CNS
xxx@blueyonder.co.uk
Epidermal Stem Cell Maturation and Lineage Commitment
xxx@ucsd.edu
Ischemic Paraplegia: Modulation by Stem Cell Implant
xxx@psbc.org GENE
TRANSFER INTO STEM CELLS BY FOAMY VIRUS VECTORS
xxx@life.uiuc.edu
Stem cell proliferation and differentiation in planaria
xxx@bidmc.harvard.edu
REGULATION OF THE HUMAN CD34 STEM CELL GENE
xxx@umn.edu
Correction of Hurler syndrome by multipotent stem cells
xxx@jax.org
Regulation of Primitive Hematopoietic Stem Cell Function
xxx@jhmi.edu Stem
Cell Therapy for Motor Neuron Disease
xxx@jhmi.edu
Experimental Hematopoietic Stem Cell Growth
xxx@path.uab.edu
Molecular Characterization of Neural Stem Cell Apoptosis
Sample Publication Titles
xxx@harvard.edu
Integrative research: the approach at the Harvard Stem Cell Institute.
xxx@hus.fi
Diagnostic criteria for hematopoietic stem cell transplant-associated
microangiopathy: results of a consensus process by an International Working
Group.
xxx@lumc.nl Phase
I/II feasibility study evaluating the generation of leukemia-reactive
cytotoxic T lymphocyte lines for treatment of patients with relapsed
leukemia after allogeneic stem cell transplantation.
xxx@med.uni-heidelberg.de
Rituximab-augmented myeloablation for first-line autologous stem cell
transplantation for mantle cell lymphoma: effects on molecular response and
clinical outcome.
xxx@humanitas.it
Ifosfamide
xxx@umm.edu Phase I
trial of first-line bortezomib/thalidomide plus chemotherapy for induction
and stem cell mobilization in patients with multiple myeloma.
xxx@mskcc.org
Systemic immunoglobulin light-chain amyloidosis.
xxx@anat.ox.ac.uk T reating muscular dystrophy with stem
cells?
xxx@med.uni-duesseldorf.de
Cell-based bone reconstruction therapies-principles of clinical approaches.
* Our database is constantly being updated and edited. Newly published
authors and grant applicants are added daily and emails which become disused
are constantly purged from our system.
| |
|